4.6 Review

Killing by Degradation: Regulation of Apoptosis by the Ubiquitin-Proteasome-System

Journal

CELLS
Volume 10, Issue 12, Pages -

Publisher

MDPI
DOI: 10.3390/cells10123465

Keywords

ubiquitin proteasome system; ARTS; Smac; XIAP; cIAP; Bcl-2; Mcl-1; parkin; p53; MDM2

Categories

Funding

  1. U.S. Israel Binational Science Foundation [2003085]
  2. Israel Science Foundation (ISF) [1264/06, 822/12]
  3. Charles Wolfson Charitable Trust
  4. Hymen Milgrom Trust
  5. INCPM-ISF [2376/15]

Ask authors/readers for more resources

Apoptosis is a crucial process for cell health and development, regulated by pro- and anti-apoptotic proteins with the ubiquitin proteasome system playing a key role in protein turnover and apoptosis modulation. Targeting these pathways presents opportunities for innovative anti-cancer therapies by recruiting the UPS for selective cancer cell killing.
Apoptosis is a cell suicide process that is essential for development, tissue homeostasis and human health. Impaired apoptosis is associated with a variety of human diseases, including neurodegenerative disorders, autoimmunity and cancer. As the levels of pro- and anti-apoptotic proteins can determine the life or death of cells, tight regulation of these proteins is critical. The ubiquitin proteasome system (UPS) is essential for maintaining protein turnover, which can either trigger or inhibit apoptosis. In this review, we will describe the E3 ligases that regulate the levels of pro- and anti-apoptotic proteins and assisting proteins that regulate the levels of these E3 ligases. We will provide examples of apoptotic cell death modulations using the UPS, determined by positive and negative feedback loop reactions. Specifically, we will review how the stability of p53, Bcl-2 family members and IAPs (Inhibitor of Apoptosis proteins) are regulated upon initiation of apoptosis. As increased levels of oncogenes and decreased levels of tumor suppressor proteins can promote tumorigenesis, targeting these pathways offers opportunities to develop novel anti-cancer therapies, which act by recruiting the UPS for the effective and selective killing of cancer cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available